Pfizer and BioNTech announce 100% efficacy of their vaccine in 12-15-year-olds

Pfizer and BioNTech announce 100% efficacy of their vaccine in 12-15-year-olds
Pfizer and BioNTech announce 100% efficacy of their vaccine in 12-15-year-olds

Pfizer / BioNTech’s Covid-19 vaccine is 100% effective in adolescents aged 12 to 15, according to clinical trial results.

This is what the two laboratories have just announced, which hope that the vaccination of this age group will begin before the next school year.

Phase 3 trials involving 2,260 adolescents in the United States “have demonstrated 100% efficacy and robust antibody responses,” the two companies said in a statement.

Pfizer and BioNTech will now submit this data to various regulatory authorities around the world “in the hope of starting to vaccinate this age group before the start of the next school year”, says Albert Bourla, CEO of the American pharmaceutical giant. , cited in the press release.

March 31, 2021 at
15:21

Modified 31 mars 2021 at 15:21

Get the latest news delivered to your inbox

Follow us on social media networks

PREV Global Road Marking Paints Market 2021 Grows Rapidly Around The Globe In Near Future | TATU, Nippon Paint, Zhejiang Brother, 3M
NEXT Analysis by Industry Size, Share, Key Factors, Growth Factors, Requirements, Manufacturers – Top Particle Measuring Systems, Spectro Scientific, HCT Instruments, Fluke, Sujing – Instant Interview